Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07482215

Prevalence and Molecular Identification of Human Schistosomiasis

Prevalence and Molecular Identification of Human Schistosomiasis With Assessment of Associated Epidemiological Risk Factors in Assiut Governorate, Egypt

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
359 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
Healthy volunteers

Summary

Schistosomiasis remains one of the most important parasitic diseases of public health concern, particularly in developing countries including Egypt. It is caused by a trematode worm (blood flukes) of the genus Schistosoma

Detailed description

Schistosomiasis has been diagnosed in Egypt since pharaonic times (3200 B.C.) by recovering Schistosome eggs and antigens in ancient mummies.In Egypt, Schistosoma mansoni and Schistosoma haematobium have historically been highly endemic, with widespread distribution along the Nile Delta and Valley.(4) Schistosoma haematobium is responsible for urogenital schistosomiasis, with hematuria as its primary manifestation, while Schistosoma mansoni, the prevalent species in Egypt, is causing intestinal schistosomiasis with liver-related sequelae

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMolecular phylogenetic and haplotype analysisDNA Sequencing and cox1 Gene Analysis of Schistosoma Isolates

Timeline

Start date
2026-05-01
Primary completion
2027-08-01
Completion
2027-12-01
First posted
2026-03-19
Last updated
2026-03-19

Source: ClinicalTrials.gov record NCT07482215. Inclusion in this directory is not an endorsement.